Impacto del tratamiento anticalcificación en la durabilidad de la bioprótesis Mitroflow y factores de riesgo para el deterioro valvular estructural

The anti-calcification treatment reduces the incidence of SVD and extends the life of the bioprosthesis. Early postoperative haemodynamic behaviour of bioprosthesis, 19 mm valve size, and patient age has also been shown to be strong risk factors for SVD.